Author:
Isbary Georg,Staab Thomas R.,Amelung Volker E.,Dintsios Charalabos-Markos,Iking-Konert Christof,Nesurini Sonja Mariotti,Walter Miriam,Ruof Jörg
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference44 articles.
1. Methods for adjusting for bias due to crossover in oncology trials;Ishak;Pharmacoeconomics,2014
2. Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations;Latimer;Med Decis Making,2014
3. The misguided ethics of crossover trials;Prasad;Contemp Clin Trials,2014
4. European Medicines Agency. Guideline on the evaluation of anticancer medicinal products in man. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/01/WC500137128.pdf. [Accessed January 14, 2016].
5. Use of the word “cure” in the oncology literature;Prasad;Am J Hosp Palliat Care,2014
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献